The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis.
- Resource Type
- Article
- Authors
- Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey
- Source
- Neurology; 12/5/2022 Suppl 2, Vol. 99, pS39-S40, 2p
- Subject
- Language
- ISSN
- 00283878